Related Experiment Video

Updated: Aug 13, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

[Next generation selective estrogen receptor modulators]

Osamu Chaki1

  • 1Section of Gynecology, Yokohama City University Medical Center.

Clinical Calcium
|January 7, 2006
PubMed

Insights

Novel selective estrogen receptor modulators (SERMs), lasofoxifene and bazedoxifene, show promise for osteoporosis prevention. These SERMs maintain bone health without adverse effects on uterine tissue or cholesterol levels.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Bone Biology

Context:

  • Osteoporosis is a significant health concern for postmenopausal women.
  • Estrogen replacement therapy offers skeletal benefits but carries risks.
  • Selective estrogen receptor modulators (SERMs) aim to provide estrogen's benefits with reduced risks.

Purpose:

  • To evaluate the efficacy of novel SERMs, lasofoxifene (LAS) and bazedoxifene (BZA), in preventing bone loss.
  • To assess the tissue-selective effects of LAS and BZA on bone, uterus, and cholesterol levels.

Summary:

  • Novel SERMs, LAS and BZA, demonstrated inhibition of bone turnover and prevention of bone loss in models of estrogen deficiency.
  • These agents did not increase uterine endometrial thickness, unlike traditional hormone therapies.
  • LAS and BZA also reduced serum cholesterol levels, suggesting cardiovascular benefits.

Impact:

  • LAS and BZA represent promising therapeutic options for osteoporosis prevention in postmenopausal women.
  • These SERMs offer a potential alternative to traditional hormone replacement therapy with an improved safety profile.
  • Further research may validate these novel SERMs for widespread clinical use in managing menopausal bone health.

More Related Videos

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay06:07

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay

Published on: June 7, 2020

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...